Correspondingly, plasma PON levels are also found to be decreased in patients with inflammatory diseases such as RA, systemic lupus erythematosus (SLE), psoriasis, and infections, clearly demonstrating that these effects are observed in a broad spectrum of diseases [127,128,129,130,131,132]. This evidence concerns the gene PON1 and systemic lupus erythematosus.